It is the latest in a string of alliances announced by Boehringer in the NASH area in recent years, coming after earlier deals with Dicerna and MiNA Therapeutics – which both involved RNA-based ...

Denmark's Novo Nordisk has agreed to pay $70 million to license rights to a drug developed by Ventus Therapeutics with ... stage candidates partnered with Dicerna and UBE. Novo Nordisk follows ...

After hours: February 7 at 4:02:41 PM EST Loading Chart for EWTX ...

After hours: February 13 at 4:09:41 PM EST Loading Chart for ACHL ...

Dyne Therapeutics Inc.-5.60% $1.56B ...